Please send media or public relations inquiries to Ben Venue Laboratories care of our Media/PR email.
Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., announced the addition of milrinone lactate in 5% dextrose injection (0.2mg / mL) in single-dose PVC flexible containers to its existing milrinone injection line. This product is AP rated and is equivalent to Primacor® by Sanofi-Aventis. Milrinone lactate in 5% dextrose injection is a bipyridine inotropic/vasodialator agent indicated for the short-term intravenous treatment of patients with acute decompensated heart failure.
"With this launch, Bedford Laboratories is pleased to offer our second product now available in a PVC flexible container. I believe this speaks to our commitment to bringing the most comprehensive and cost effective line of injectables to our customers," said David Gaugh, Vice President and General Manager of Bedford Laboratories.
In addition to the three glass vial presentations, Bedford Laboratories will supply milrinone lactate in 5% dextrose injection in two sterile ready-to-use dilutions in the following presentations: 20mg / 100mL in single-dose PVC flexible containers packaged in cartons containing 10 bags and 40mg / 200mL in single-dose PVC flexible containers packaged in cartons containing 10 bags.
Prescribing information is available upon request from Bedford Laboratories' professional services department at 1-800-521-5169, or from the company's website, www.bedfordlabs.com.
Primacor® is a registered trademark of Sanofi-Aventis